Planning and guidance of complex percutaneous coronary interventions

Prof Andrew Sharp qualified from Edinburgh Medical School in 1998 and is Professor of Cardiology at the University Hospital of Wales and Cardiff University in the U.K. He conducted his early training at the Royal Infirmary of Edinburgh, before moving to London for his senior clinical training. He completed the prestigious Milan-Imperial Interventional Cardiology Fellowship programme, having spent a year in San Raffaele and Columbus Hospitals, Milan, Italy, under the tutelage of Professor Antonio Colombo. He also spent three years training in interventional cardiology at Imperial College Hospitals in London. Prof Sharp was awarded an MD postgraduate research degree from the University of Edinburgh for his work on the hypertensive heart and his research interests include intracoronary imaging and physiology. as well as the use of device-based treatments for hypertension and pulmonary embolism.

Angela McInerney is an Interventional Cardiologist at University Hospital Galway, Ireland. Following completion of her basic cardiology training in Ireland she was awarded the Brian McGovern Travelling Fellowship grant from the Irish Board for Cardiology Training in 2018 which allowed her to start her interventional fellowship in Hospital Clínico San Carlos, Madrid, Spain. Following two years of coronary training including complex PCI, she was awarded an European Society of Cardiology Fellowship Training Grant and completed a further year of structural intervention also in Clínico San Carlos, Madrid. Her specialist interests are in intracoronary imaging, intracoronary physiology, calcium modification techniques and complex PCI. She has been keenly involved in various research projects pertaining to intracoronary physiology and intravascular imaging having authored and co-authored a number of research articles as well as review articles and book chapters on these topics. During her fellowship she also regularly partook in the preparation and delivery of educational courses in Clínico San Carlos and values the educational aspect of her role as a Consultant Interventional Cardiologist.

Dr Ashok Seth is Chairman of Fortis Escorts Heart Institute, New Delhi and Adjunct Professor of Cardiology at JN Medical College (Aligarh Muslim University) and National Board of Examinations. Dr Seth has led the field of Interventional Cardiology for last 33-years and has contributed extensively to the development, scientific progress and education in this field and pioneered numerous angioplasty techniques for India and Asia Pacific. Dr Seth has been awarded by the National Honour of Padma Shri in 2003, Padma Bhushan in 2015 and ‘B.C.Roy National Award’ for the ‘Eminent Medical Person’ by the President of India in 2017. He has also been awarded the National Honour of Republic of Spain “Crus Officer with Insignia Order of Isabella the Catholic”, Master Interventionalist (MSCAI) by the Society for Cardiovascular Angiography & Interventions (USA) in addition to 90 other national and international awards. Dr Seth has been honoured by Doctorates from six prestigious national universities. He has been conferred ‘Adjunct Professorship of Cardiology’ of J N Medical College, Aligarh Muslim University and the National Board of Examinations. He is Founder/Course Director of five major National & International Teaching Courses - India Live, India Valves, CHIP-CTO India, AICT-AsiaPCR and Imaging & Physiology Council of India. He is also Associate Director of TCT Scientific Sessions (USA) and Program Committee Member of EuroPCR. Dr Seth has been invited to lecture at more than 600 national & international meetings and to teach complex angioplasty techniques through Live Demonstration at more than 150 national & international meetings around the world. He has more than 400-publications to his credit in peer reviewed Indian and International medical journals and has chapters in 30-books on Cardiology and has been the Editor of 3-books. He is an acclaimed teacher and has trained more than 500-cardiologists of India and abroad in advanced techniques of angioplasty.

Dr Billal Patel is Head of Interventional Cardiology at Lancashire Cardiac Centre (Blackpool, UK). He trained as a cardiologist in Liverpool, He obtained his PhD in Coronary Microvascular Dysfunction from the University of Liverpool. United Kingdom before moving to the Lancashire Cardiac Centre. He has presented TCT, EuroPCR and ACI. His special interests include ultra low contrast PCI, intracoronary imaging, left main bifurcations, mentorship for trainees and education. Research interests include coronary physiology and microvascular dysfunction. Some of his additional interests are Brazilian Jiu-jitsu and hill walking.

Dr Breda Hennessey graduated from the Third Faculty of Medicine in Charles University in Prague. Following this, she returned to Ireland to complete her general medical and higher specialist cardiology training. In 2019, she was awarded the Brian McGovern Scholarship by the Irish Cardiac Society, and this allowed her to commence her subspecialty training in Interventional Cardiology at Hospital Clínico San Carlos in Madrid. She completed a two-year coronary interventional fellowship, with a focus on intracoronary imaging, invasive physiology and ultra-low dose contrast intervention. Following completion of her coronary training, she undertook a further fellowship in structural intervention, also at Hospital Clínico San Carlos. In addition to her clinical work, she has been involved in various research projects pertaining to ultra-low dose contrast PCI, investigating the impact of new technologies in reducing contrast burden in complex PCI . She has authored and co-authored a number of research articles, book chapters and has contributed to the European association of Percutaneous Cardiovascular Interventions textbook. During her time at Hospital Clinico San Carlos, she completed a Masters in Interventional Cardiology and is currently undertaking a PHD at the Complutense University of Madrid with a focus in ultra-low dose contrast PCI. Throughout her fellowship, she regularly took part in the preparation and delivery of educational courses, both at Hospital Clinico San Carlos and in collaboration with other tertiary referral centres and international cardiology societies in Spain, the UK and the UAE.

Davide Cao is senior research fellow at the Center for Interventional Cardiovascular Research and Clinical Trials at the Icahn School of Medicine at Mount Sinai, New York, where he is involved in the design and management of randomized clinical trials, prospective registries, and many retrospective studies. Davide Cao graduated in Rome, from Campus Bio-Medico University, and completed his general cardiology training in Milan, at Humanitas University. He is now an interventional cardiology fellow at Institute Mutualiste Montsouris in Paris. His research focuses on coronary stents and management of antithrombotic therapy, particularly in high-risk subsets of patients.

Dr Dejan Milasinovic is an interventional cardiologist at the Department of Cardiology, Clinical Center of Serbia. He is also an Assistant Professor at Faculty of Medicine, University of Belgrade. His main research interests focus in the fields of the invasive treatment of acute coronary syndromes and complex coronary interventions, with an emphasis on bifurcation PCI and intracoronary guidance. In 2016, Dr Milasinovic received the EuroPCR 2016 Best Abstract award, for a work on the timing of invasive coronary intervention in patients with non-ST-segment elevation myocardial infarction. He is a member of European Association of Percutaneous Cardiovascular Interventions (EAPCI) and has served as program committee member of the annual EuroPCR conference. Dr Milasinovic also serves on the editorial boards of EuroIntervention (editorial consultant) and PCRonline and is the Chair of the EAPCI Young committee.

Prof Erick Schampaert is a Professor of Medicine, University of Montreal. He has been Interventional cardiologist, Hôpital du Sacré-Cœur de Montreal, since 1997, serving as Head of Division of Cardiology since 2006; Chair, CIUSSS NIM HSCM Cardiovascular Health Program since 2014 and Director of Clinical CV Research unit since 2001. Prof Schampaert’s research is focused mainly on Left Main PCI, Coronary physiology (FFR, iFR, CFR), Coronary imaging (IVUS and OCT), and ACS (STEMI) and platelet functions. Prof Schampaert is a Local PI for more than 75 clinical trials and is an author or co-author of more than 75 manuscripts in journals such as NEJM, Lancet, Circulation, JACC, EHJ.

A medical doctor at Division of Cardiology, University of Turin, Italy. Features in 3 videos on Wondr Medical. Fabrizio d'ascenzo generally speaks on Stents, Medical Device, Coronary Intervention: Devices, High Bleeding Risk, and Cardiology: Webinar.

Prof Goran Stankovic is a Professor of Internal Medicine and Cardiology at the Faculty of Medicine, University of Belgrade, Head of the Department of Cardiology, Clinical Center of Serbia and Chief of Invasive Diagnostics and Interventional Cardiology. Prof. Stankovic was awarded Fellow of the European Society of Cardiology (FESC) in 2003, and Fellow of the American College of Cardiology (FACC) in 2005. He has been a member of European Association for Percutaneous Coronary Interventions (EAPCI) since 2007 and is currently a member of the EAPCI Nominating Committee. He has been one of the founding members and is currently the president of the European Bifurcation Club, and a member of the Asian and Indian Bifurcation Clubs. Professor Stankovic serves on the editorial boards of Journal of the American College of Cardiology, Eurointervention, European Journal of Cardiovascular Medicine, Advances in Interventional Cardiology Journal, and Heart and Blood Vessels – Journal of Cardiology Society of Serbia. For the consecutive years 2005-2014 Professor Stankovic was awarded Elite Reviewer for Journal of American college of Cardiology. In 2009 he received Simon Dack Award for outstanding Scholarship from the American College of Cardiology Foundation.

Prof Hitoshi Matsuo is currently President of Gifu Heart Center,
and Clinical Visiting Professor of Cardiology in Aichi Medical University. He graduated from Jichi Medical School in 1986 and completed his residency in Gifu Prefectural Gifu Hospital. In 1987, during his residency period, Prof Hitoshi Matsuo spent one year at Johns Hopkins Medical Institutions in Baltimore as a research fellow in the Nuclear Medicine Department under the supervision of Professor Henry N Wagner Jr. From 1988, he returned to Gifu Prefectural Hospital where he dedicated clinical research work on physiology and interventional cardiology using nuclear medicine and pressure wires. He received an annual award of Japanese Society of Nuclear Medicine in 1995 and the Clinical Research Award of Japanese Society of Interventional Cardiology in 2004. Thereafter, he moved to Toyohashi Heart Center as co-director of the catheterization laboratory from 2007 and returned to Gifu as the Director of Cardiovascular Medicine in 2009. Dr Matsuo now participates and contributes to many international multi-center trials including DEFINE-FLAIR, the international multicenter FFRCT registry (ADVANCE registry), 3V-FFR FRIENDS study and FAVOR2 Europe and Japan, DEFINE FLOW study.

Prof Javier Escaned is Head of Section (Interventional Cardiology Section) at Hospital Clinico San Carlos / Complutense University (Madrid, Spain). He trained in the United Kingdom as Specialist in Cardiology and obtained his PhD in The Netherlands. Author of >600 indexed scientific articles on interventional cardiology, imaging and physiology (h-index 74) and over 30 years of experience as PCI operator, he regularly lectures and performs live cases at major scientific and educational meetings. He is a recipient of the European Society of Cardiology (ESC) Silver Medal and the Andreas Grüntzig Award for his contributions to the fiedl fo Interventional Cardiology. Main areas of expertise include complex PCI, intracoronary diagnostics and functional coronary angiography. His track record in coronary physiology comprises being investigator on pioneer FFR trials like DEFER (1998), collaborator with Justin Davies in the validation and clinical implementation of iFR, and developer of new tools for the assessment of coronary microcirculation. Editorial roles include Deputy Editor EHJ, Advisory Editor Eurointervention, editor of the textbooks “Coronary Stenosis: Imaging, Structure and Physiology” and “Physiological Assessment of Coronary Stenoses and the Microcirculation". Recent board positions include EAPCI board / Education Committee Chair, ESC WG Coronary Pathophysiology and Microcirculation, EuroCTO Board. Recent trials as Principal Investigator include ADVISE II, DEFINE FLAIR, SYNTAX II, PIONEER IV, Cerebral-Coronary-Connection (C3), DCR4Contrast, INOCA LongCovid and AID ANGIO. Additional interests are philosophy and music.

Jeroen Sonck is co-director of the Cardiovascular Center Aalst in Belgium. He is also director of CoreAalst BV, conducting research mainly in coronary interventions and physiology with a strong focus on innovation. He was trained in UZ Brussels University Hospital, Catharina Hospital Eindhoven and joined the Aalst team in 2018. His main clinical activities concentrate on complex PCI and the use of non-invasive coronary imaging and coronary physiology to guide coronary revascularization. Dr. Sonck has renowned proficiency in coronary CT, CT-derived FFR and was involved in the early development and validation of virtual PCI using the FFR-CT Planner. He participated in innovative research bringing coronary CT in the cathlab (CT-guided PCI) and developed with his colleague Dr. Carlos Collet the Pullback Pressure Gradient describing the pattern of CAD to improve physiology-guided PCI. He served as the PI of several studies. Together with the interventional team in Aalst Jeroen Sonck has already trained multiple fellows in imaging, physiology and PCI.

Prof. Mehilli is the Chief of the First Medical Clinic (Cardiology/Pulmonology/Intensive Medicine) at the Hospital Landshut-Achdorf and Professor for Cardiology at the Ludwig-Maximilians University, Munich, Germany. Before her appointment as Clinic Chief in September 2020, she was for 10 years director of the catheterisation laboratories first at the Deutsches Herzzentrum thereafter at the LMU University Clinic in Munich and was responsible for both coronary and structural invasive programs. With more than 6000 PCIs and more than 2000 catheter-based valvular procedures, she is one of the most experienced operators in Germany Prof Mehilli spend nearly 20 years with clinical research, first as co-founder and co-director of the well-known ISAResearch Zentrum, thereafter as leader of the working group Minimal-Invasive Cardiology at the LMU Clinic and Principal Investigator at the German Center for Cardiovascular Research (DZHK) . She has led many national and international multicentre trials and authored a multitude of high-ranking publications with a total impact factor of more than 4000. She is member of various boards and cardiologic societies – AGIK, EAPCI, DGK, ESC, Women-EAPCI as well as associate editor for medical journals as European Heart Journal, Journal American College of Cardiology and EuroIntervention.

Dr Justin Davies is a honorary 
interventional cardiologist at Hammersmith Hospital, Imperial College NHS Trust, London. After training at Imperial College, he won a prestigious BHF research fellowship to study arterial haemodynamics. Since then he has continued to
work on the development of mathematical algorithms to aid understanding of large artery physiology and to develop new tools to assess arterial disease. The holder of several patents,
he has published widely in the field of hypertension, coronary and large artery physiology and is the winner of many national and international awards. He has several international collaborations, and is the developer of iFR and the co-principal investigator of the ADVISE studies, the DEFINE-FLAIR, ORBITA and DEFINE-PCI studies. Justin also has an interest in renal denervation, and has lead the first-in-man studies to evaluate the safety of this technique to patients with chronic systolic heart failure (REACH studies).

Dr Kambis Mashayekhi is Head of the Department of Internal Medicine and Cardiology in Heart Center Lahr in Germany. Dr. Mashayekhi is performing over 350 CTO-PCI’s per year and is an world-renowned CTO and complex PCI specialist. Dr. Mashayekhi is the head of the CTO working group from the German Society of cardiology and the Co-Director of MLCTO and EuroCTO course. He is the new EuroCTO president elect for 2023.

A cardiologist at Research Center for Coronary Heart Disease,Fuwai Hospital. Features in 1 video on Wondr Medical. Lei Song generally speaks on Coronary Angiograpy, Angio FFR/iFR, Instantaneous wave-Free Ratio (iFR), Stable Coronary Artery Disease (CAD), and IMR.

Prof Maciej Lesiak is Head of the 1st Department of Cardiology in Poznan Medical University and a cardiology consultant in Greater Poland province. He obtained medical diploma at the Medical Academy in Poznan (currently the Medical University) and at this university he gained further academic degrees and promotions. He received his doctorate in 1995 defending the work entitled Structure of the sinus node in healthy persons and patients with supraventricular rhythm disorders. His specialization is internal diseases and cardiology.In 2001, he was a member of the team of Poznan cardiologists who prepared the first program for the invasive treatment of acute myocardial infarction in Greater Poland province. In 2007, he became Associate Professor based on the assessment of scientific achievements and dissertation titled “Primary coronary angioplasty in the treatment of acute phase of myocardial infarction. Early and long-term observation of 988 consecutive patients treated as part of the Greater Poland Province Program”. Prof Lesiak became a Professor of medical sciences in 2016. Prof Lesiak has been a member of the Board of the Working Group for Invasive Cardiology of The Polish Cardiac Society since 2001, and its president in years 2009 - 2011; Member of European Society of Cardiology since 2002, and a EuroPCR Program Committee Member since 2009. He is also an associate editor of the Polish Heart Journal. Prof Lesiak has published over 140 original publications in magazines such as European Heart Journal, JACC, JACC Cardiovascular Interventions, American Heart Journal, etc.

Dr Mauro Echavarría Pinto is an Interventional cardiologist and currently works at “ISSSTE“ General Hospital in Querétaro, México. He trained clinically in the National Institutes of Health, in Mexico City, and in Hospital Clínico San Carlos, in Madrid, Spain. He holds a MSc degree in Research Methodology, Design and Statistics in Health Sciences from the Autonomous University of Barcelona, Spain, and a PhD from the University of Amsterdam, The Netherlands. He is an author of >50 peer-reviewed manuscripts mostly focused on the use of coronary physiology to guide the treatment of ischaemic heart disease.

Dr. Pinilla-Echeverri is originally from Colombia and received her MD from Universidad de Caldas in Manizales, Caldas, Colombia. She moved to Spain to complete training in Internal Medicine and Cardiology and then moved to Canada to complete an Interventional Cardiology, non-invasive Cardiac Computed Tomography Angiography imaging and advanced Intracoronary Imaging fellowship at McMaster University, Hamilton, Canada. She also obtained a Master’s Degree in Health Research Methodology from Universidad de Cordoba; and PhD Degree from Universidad Complutense in Madrid, Spain. She actively participates in Acute Coronary Syndrome research at the Population Health Research Institute. Dr. Pinilla-Echeverri is an Associate Professor at the Department of Medicine Division of Cardiology at McMaster University and currently an Interventional Cardiology Staff at Hamilton Health Sciences and Niagara Health. She is the Program Director of the Intravascular Coronary Imaging Fellowship in McMaster University and has trained international interventional cardiologists in Imaging. She is passionate about acute coronary syndrome research and leads educational programs worldwide.

Nicola Ryan is a Consultant Interventional Cardiologist in Aberdeen Royal Infirmary and the University of Aberdeen, Scotland. She received her medical degree from the Royal College of Surgeons in Ireland (2008), followed by Internal Medicine (2011) and Cardiology training (2015) through the Royal College of Physicians in Ireland. Thereafter, she completed a prestigious Interventional Cardiology and research fellowship in Hospital Clínico San Carlos, Madrid (2017). Dr Ryan's interests are primarily in the role of intra-coronary physiology and imaging, which she routinely applies in her clinical practice as well as in the clinical interventional research she leads in Aberdeen. She engages as a reviewer for several high impact journals. Dr Ryan is a member of the EuroPCR Scientific Committee and the PCR NextGen group, as well as a member of the European Society of Cardiology fellowship committee.

Niels van Royen is an interventional cardiologist and Head of Department of Cardiology at the Radboud University Medical Center, Nijmegen, the Netherlands. He has a background in pre-clinical research and is head of a research group on translational research in repair mechanisms in ischemic heart disease. Also he is principal investigator of several multi-center clinical trials like the TRANSIENT, COACT, REDUCE-MVI and iMODERN. These trials focus on timing of interventional procedures as well as the use of intra-coronary physiology to guide interventional procedures both in stable coronary artery disease as well as acute coronary syndromes.

Dr Nieves Gonzalo is Consultant Interventional Cardiologist at the Interventional Cardiology Department at Clinico San Carlos University Hospital in Madrid. She obtained her Specialist Certification in Cardiology after training at Clinico San Carlos University Hospital in Madrid. Subsequently, she underwent a research fellowship at Thoraxcenter, Erasmus University Rotterdam (The Netherlands) under the supervision of Professor Patrick Serruys, focused mainly in intracoronary imaging and bioabsorbable stents. In 2010 she obtained her PhD with the thesis “Optical coherence tomography for the assessment of coronary atherosclerosis and vessel response after stent implantation”. Her track record includes over 170 articles indexed in PubMed, as well as book chapters in Interventional Cardiology textbooks. Recent research projects as principal investigator includes a study about the assessment of neoatherosclerosis and its clinical impact in patients with restenosis (RIBS IV and V OCT substudy) and research regarding vessel injury and healing evaluation with different stent platforms evaluated with OCT (VISTA study). Dr Gonzalo is a dedicated educationalist with involvement in many areas of complex PCI, serving currently as Deputy Editor for Eurointervention and Committee Member of EuroPCR.

Dr. Pablo Salinas is Interventional Cardiologist at Hospital Clínico San Carlos in Madrid, Spain. He studied Medicine at Universidad Complutense in Madrid, Spain and was trained in Cardiology and Interventional Cardiology at Hospital La Paz in Madrid, Spain. In 2015 he obtained his PhD degree (cum laude) at the Universidad Autonoma in Madrid. He has developed his professional career in the field of interventional cardiology for over 10 years, and is a skilled operator in complex coronary intervention, chronic occlusions, and stroke prevention therapies such as foramen ovale closure and appendage closure, with regular participation in educational events and live cases. During his research career he has 80+ PubMed indexed publications and is currently the PI of three multicenter studies SUGAR Trial (NCT03321032), REVASEC Registry (NCT03349385), and TROMPA Registry. Also he has been researcher in several investigator initiated, competitive funding research (PI16 / 00840, PIE16 / 00043, PI15 / 00742).

Prof Patrick W. Serruys with respected h-index – 183 is a professor of Interventional Cardiology at the Interuniversity Cardiological Institute of the Netherlands (1988-1998) and Erasmus MC. Since 1980 he was a Director of the Clinical Research Program of the Catheterization Laboratory, Thorax Center at Erasmus University, and till April 1, 2014 (retirement date) the Head of the Interventional Department, Thorax Center, Erasmus MC (University Medical Center Rotterdam), Rotterdam, The Netherlands. Since April 2013, he holds the position of Professor of Cardiology in the Cardiovascular Science Division of the National Heart and Lung Institute (NHLI) at the Faculty of Medicine, within the Imperial College of Science, Technology and Medicine, London.He is a Fellow of the American College of Cardiology and a Fellow of the European Society of Cardiology and scientific council of the International College of Angiology.In 1996, he received the TCT Career Achievement Award and in 1997 he was awarded the Wenkebach Prize of the Dutch Heart Foundation. In 2000, he was awarded the Gruentzig Award of the European Society of Cardiology. In 2001, he held the Paul Dudley White Lecture at the American Heart Association in the USA. In 2004, he received the Andreas Gruentzig Award of the Swiss Society of Cardiology. In 2005, he held the 4th International Lecture at the AHA and Mikamo Lecture at the Japanese heart Association. In 2006, he received the highest award of the Clinical Council of the American Heart Association: the James Herrick Award. In 2007, he received the Arrigo Recordati International Prize (Italy) and the ICI Achievement Award (bestowed by the President of Israel – Shimon Perez). In 2008, he received the Einthoven Penning (Leiden). In 2009, he became Doctor Honoris Causa from the University of Athens. In 2011, he received the Lifetime Achievement Award, bestowed by the American College of Cardiology, in recognition of many years of service and invaluable contributions to the ACC. At the end of 2011, Prof Serruys received the Ray C. Fish Award, bestowed by the Texas Heart Institute, for outstanding achievement and contribution to cardiovascular medicine. In 2012, he received a Golden Medal of the European Society of Cardiology. In 2013, he became Doctor Honoris Causa from the Complutense University of Madrid. In 2016, he became Doctor Honoris Causa of the Melbourne University, Australia. Currently he is established Professor of Interventional Medicine and Innovation at the National University of Ireland, Galway.

Dr Richard A. Shlofmitz, MD, FACC is the Chairman of Cardiology at St. Francis Hospital, The Heart Center®, in Roslyn, New York. A pioneer in interventional cardiology, Dr. Shlofmitz has worked to advance the field, with a focus on optimizing outcomes with the development of Precision PCI. He is a founding co-director of the annual Intravascular Imaging and Coronary Physiology Workshop. Performing over 1,000 coronary interventions annually, he has one of the largest volumes of experience in PCI. He has the most clinical experience with orbital atherectomy and OCT world-wide. His clinical research interests focus on optimizing coronary interventions and he serves on multiple scientific advisory boards and clinical trial steering committees to further this mission. Dr Shlofmitz has been one of the largest enrollers for multiple clinical trials, including TWILIGHT, ILUMIEN III, and Onyx, with more than 75 publications in peer-reviewed journals and was first to perform coronary intravascular lithotripsy (IVL) in North America as part of the DISRUPT CAD III trial.

Prof. Byrne graduated from University College Dublin, Ireland and completed his PhD in Medical Life Science and Technology at the Technical University Munich, Germany. Research awards received include the ESC Atherothrombosis Research Fellowship (2008), the TCT Thomas J. Linnemeier Young Investigator Award (2009) and the Andreas Grüntzig Research Prize of the German Cardiac Society (2016). Leadership roles include Deputy Editor at EuroIntervention and board member of EAPCI and Chair of its Patient Initiatives Committee.

A cardiologist at McMaster University, Ontario, Canada. Features in 1 video on Wondr Medical. Shamir Mehta generally speaks on Primary Percutaneous Coronary Intervention (PPCI) and ST-Elevation Myocardial Infarction (STEMI).

Senior staff cardiologist and Director of cardiac catheterisation laboratories, Liverpool hospital, Sydney, Australia. Chair, Interventional council, Cardiac Society of Australia and New Zealand. Convener ANZET. Director (Australia) APCTO club. Interests include protected PCI, intracoronary imaging and physiology, Cardiogenic shock, TAVI, ACS adjunctive pharmacology and AF anticoagulation.

Simone Biscaglia has worked as an Interventional Cardiologist at Ferrara University Hospital since 2015. He graduated from Bologna University School of Medicine and Ferrara University School of Cardiology. He is also a Researcher in the field of coronary physiology, myocardial infarction, frailty, bioresorbable vascular scaffolds, physical activity and neural interfaces. He has 90 articles indexed on Pubmed and is the Principal Investigator of the ongoing international randomised FIRE trial which recently concluded the enrollment of 1400 older MI patients with MVD.

Dr Vasileios Panoulas is a Consultant Interventional Cardiologist at the Royal Brompton and Harefield hospitals, part of the Guys and St Thomas NHS Foundation Trust and Honorary Senior Clinical Lecturer at Imperial College London. He has clinical expertise that encompasses both general and interventional cardiology. He is a high volume PCI and TAVI (trans catheter aortic valve implantation) operator with interest in complex high risk PCI and use of mechanical circulatory support (MCS) in patients with cardiogenic shock. Dr Panoulas' research interests involve clinical outcomes with new generation TAVI devices, use of MCS in patients presenting with cardiogenic shock, management of acute coronary syndromes (ACS) and hypertension. Other interests include speckle tracking and hand-held echocardiography and cardiovascular disease in patients with rheumatoid arthritis.